Skyrizi – Talk Bio

Actionable Insights Powered by AI

AbbVie’s New CEO Rob Michael Earns $18.5M in First Year as Humira Succession Plan Unfolds

1 month ago talkbio0Tagged AbbVie CEO, Humira patent expiration, Pharmaceutical executive pay, Rinvoq growth, Rob Michael compensation, Skyrizi, succession

AbbVie CEO succession, Rob Michael compensation, Humira patent expiration, Skyrizi and Rinvoq growth, Pharmaceutical executive pay

AbbVie’s Skyrizi Secures Key FDA Approval for Ulcerative Colitis Treatment

10 months ago talkbio0Tagged AbbVie, Approved, Crohn 's disease, Inflammatory Bowel Diseases, Inhibitor, interleukin-23, Skyrizi, Ulcerative Colitis, United States Food and Drug Administration

Skyrizi, AbbVie, FDA approval, ulcerative colitis, inflammatory bowel disease, IL-23 inhibitor, Crohn’s disease